AKT1 and pulmonary fibrosis: Under sustained pathological stimulation, this negative feedback often proves insufficient to counteract the intensely activated positive signals, ultimately leading to abnormal activation of the PI3K/AKT pathway—potentially a key mechanism in diseases like pulmonary fibrosis.